Coronavirus: India’s COVID-19 caseload reaches 43-lakh mark; five states account for 62% of active cases

India's COVID case tally crosses 43-lakh mark with a spike of 89,706 new cases and 1,115 deaths, reported in the last 24 hours

<p>India's COVID-19 case tally crossed the 43-lakh mark with a spike of 89,706 new cases and 1,115 deaths reported in the last 24 hours.</p>

India's COVID-19 case tally crossed the 43-lakh mark with a spike of 89,706 new cases and 1,115 deaths reported in the last 24 hours.

<p>The total case tally stands at 43,70,129 including 8,97,394 active cases, 33,98,845 cured/discharged/migrated and 73,890 deaths, showed ministry of health data on Wednesday (September 9).<br />&nbsp;</p>

The total case tally stands at 43,70,129 including 8,97,394 active cases, 33,98,845 cured/discharged/migrated and 73,890 deaths, showed ministry of health data on Wednesday (September 9).

<p>According to the health ministry, Maharashtra, Andhra Pradesh, Karnataka, Uttar Pradesh and Tamil Nadu account for 62% of total active coronavirus cases in the country.</p>

According to the health ministry, Maharashtra, Andhra Pradesh, Karnataka, Uttar Pradesh and Tamil Nadu account for 62% of total active coronavirus cases in the country.

<p>Maharashtra, the worst-hit state on Tuesday reported 20,131 new COVID-19 cases, taking its tally to 9,43,772, while the death toll went up to 27,407 with 380 patients succumbing to the infection, state health department said.</p>

Maharashtra, the worst-hit state on Tuesday reported 20,131 new COVID-19 cases, taking its tally to 9,43,772, while the death toll went up to 27,407 with 380 patients succumbing to the infection, state health department said.

<p>Maharashtra accounts for 27% of the total active cases, Andhra Pradesh 11%, Karnataka 10.98%, Uttar Pradesh about 7%, and Tamil Nadu around 6%.<br />&nbsp;</p>

Maharashtra accounts for 27% of the total active cases, Andhra Pradesh 11%, Karnataka 10.98%, Uttar Pradesh about 7%, and Tamil Nadu around 6%.

<p>India has crossed the five-crore mark for sample testing of the novel coronavirus as of September 7, informed the Indian Council of Medical Research (ICMR) on Tuesday, adding that 10,98,621 samples were tested for the pathogen on Monday.<br />&nbsp;</p>

India has crossed the five-crore mark for sample testing of the novel coronavirus as of September 7, informed the Indian Council of Medical Research (ICMR) on Tuesday, adding that 10,98,621 samples were tested for the pathogen on Monday.

<p>Phase-3 clinical trials of a coronavirus vaccine being developed by AstraZeneca, in collaboration with Oxford University, have been halted worldwide after one participant in England reported serious side-effects.</p>

Phase-3 clinical trials of a coronavirus vaccine being developed by AstraZeneca, in collaboration with Oxford University, have been halted worldwide after one participant in England reported serious side-effects.

<p>The clinical trials for the COVID-19 vaccine candidate developed by the University of Oxford, which was expected to start at PGIMER in Chandigarh, have been delayed by at least a week over safety approvals.</p>

The clinical trials for the COVID-19 vaccine candidate developed by the University of Oxford, which was expected to start at PGIMER in Chandigarh, have been delayed by at least a week over safety approvals.